Evolution of Charcot–Marie–Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lupski JR, de Oca-Luna RM, Slaugenhaupt S et al (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232
Raeymaekers P, Timmerman V, Nelis E et al (1991) Duplication in chromosome 17p11.2 in Charcot–Marie–Tooth type 1A (CMT1A). The HSMN collaborative research group. Neuromuscul Disord 1:93–97
Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280
Berciano J, Combarros O, Calleja J, Polo JM, Leno C (1989) The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12:302–306
García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiological study. Neurology 50:1061–1067
Hoogendijk JE, De Visser M, Bolhuis PA, Hart AA, Ongerboer de Visser BW (1994) Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17:85–90
Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176
Berciano J, Gallardo E, García A, Ramón C, Infante J, Combarros O (2010) Clinical progression in Charcot–Marie–Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family. J Neurol 257:1633–1641
Birouk N, Goudier R, Le Guern E et al (1997) Charcot–Marie–Tooth type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823
Shy ME, Chen L, Swan ER et al (2008) Neuropathy progression in Charcot–Marie–Tooth type 1A. Neurology 70:378–383
Verhamme C, van Schaik IN, Koelman JHTM, de Haan RJ, de Visser M (2009) The natural history of Charcot–Marie–Tooth type 1A in adults: a 5-year follow-up study. Brain 132:3252–3262
Padua L, Pareyson D, Aprile I et al (2008) Natural history of CMT1A including QoL: a 2-year prospective study. Neuromuscul Disord 18:199–203
May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 20:295–315
Farber JM, Buckwalter KA (2002) MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin N Am 40:1013–1031
Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437
Chung KW, Suh BC, Shy ME et al (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618
Kamath S, Venkatanarasimha N, Walsh MA, Hughes PM (2008) MRI appearance of muscle denervation. Skeletal Radiol 37:397–404
Ginsberg L, Malik O, Kenton AR et al (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202
Van der Ploeg RJ, Fidler V, Oosterhuis HJ (1991) Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 54:244–247
Beenaker EA, van der Hoeven JH, Fock JM et al (2001) Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 by hand-held dynamometry. Neuromusc Disord 11:441–446
Solari A, Laurà M, Salsano E, Pareyson D, CMT-TRIAAL Study Group (2008) Reliability of clinical outcome measures in Charcot–Marie–Tooth disease. Neuromuscul Disord 18:19–26
Berciano J, Gallardo E, García A, Pelayo-Negro AL, Infante J, Combarros O (2011) New insights into the pathophysiology of pes cavus in Charcot–Marie–Tooth disease type 1A duplication. J Neurol 258:1594–1602
Shy ME, Blake J, Krajewski K et al (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
Preston DC, Shapiro BE (2005) Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations, 2nd edn. Elsevier, Philadelphia
Bleasel AF, Tuck R (1991) Variability of repeated nerve conduction studies. Electroencephalogr Clin Neurophysiol 81:417–420
Hashimoto S, Kawamura J, Segawa Y, Harada Y, Hanakawa T, Osaki Y (1994) Waveform changes of compound muscle action potential with muscle length. J Neurol Sci 124:21–24
Rosenfalk P, Rosenfalk A (1975) Electromyography, sensory and motor conduction findings in normal subjects. Publication from the Laboratory of Clinical Neurophysiology. Rigshospitalet, Copenhagen
Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC (1994) Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 304:78–83
Berciano J, García A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication. Neuromuscul Disord 10:419–424
Berciano J, García A, Combarros O (2003) Initial semeiology in children with Charcot–Marie–Tooth disease 1A duplication. Muscle Nerve 27:34–39
Krajewski KM, Lewis RA, Fuerst DR et al (2000) Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A. Brain 123:1516–1527
Videler AJ, Beelen A, van Schaik IN et al (2010) Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot–Marie–Tooth disease type 1A. J Neurol Neurosurg Psychiatry 8:828–833
Van der Linden MH, van der Linden SC, Hendricks HT, van Engelen BG, Geurts AC (2010) Postural instability in Charcot–Marie–Tooth type 1A patients is strongly associated with reduced somatosensation. Gait Posture 31:483–488
Burns J, Ryan MM, Ouvrier RA (2009) Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 39:158–166
Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, Van Doorn PA (2000) Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory neuropathy cause and treatment (INCAT) group. Neurology 54:943–949
Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, Vermeulen M, de Visser M (2004) Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 251:1491–1497
Komyathy K, Neal S, Feely S et al (2013) Anterior tibialis CMAP amplitude correlations with impairment in CMT1A. Muscle Nerve 47:493–496
Hollingsworth KG, de Sousa PL, Straub V, Carlier PG (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France. Neuromuscul Disord 22:S54–S67